Sagar Lonial Tg Therapeutics, Inc. (TGTX) insider trading activity

Sagar Lonial is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 100,195 shares of TGTX, which is worth approximately $3.51 Million. The most recent transaction as insider was on Nov 11, 2024, when has been sold 5,000 shares (Common Stock) at a price of $30.44 per share, resulting in proceeds of $152,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

4.75% 3M change

12.02% 12M change

Total Value Held $3.51 Million

Sagar Lonial Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$152,200 $30.44 p/Share	5,000 Reduced 4.75%	100,195 Common Stock
Jun 20 2024	SELL Open market or private sale	$275,790 $16.87 p/Share	16,348 Reduced 13.45%	105,195 Common Stock
Jun 19 2024	BUY Grant, award, or other acquisition	-	22,250 Added 15.47%	121,543 Common Stock
Jun 17 2024	SELL Open market or private sale	$157,098 $16.39 p/Share	9,585 Reduced 8.8%	99,293 Common Stock
Mar 13 2024	SELL Open market or private sale	$79,700 $15.94 p/Share	5,000 Reduced 4.39%	108,878 Common Stock
Sep 28 2023	SELL Grant, award, or other acquisition	-	20,000 Reduced 14.94%	113,878 Common Stock
Jun 23 2023	SELL Open market or private sale	$814,537 $23.37 p/Share	34,854 Reduced 27.07%	93,878 Common Stock
Jul 20 2022	BUY Grant, award, or other acquisition	-	43,732 Added 25.36%	128,732 Common Stock
Jun 18 2021	BUY Grant, award, or other acquisition	-	20,000 Added 19.05%	85,000 Common Stock

Sagar Lonial

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Value

Insider Trading

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to TG THERAPEUTICS, INC.

Track Activities on TGTX

Account